Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; AE; adverse event; BCVA; best-corrected visual acuity; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; HbA1c; hemoglobin A1c; NPDR; nonproliferative diabe
مقالات ISI مقیاس شدت گیری رتینوپاتی دیابتی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; BCVA; best-corrected visual acuity; BMI; body mass index; CST; central subfield thickness; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; HbA1c; hemoglobin A1c; IAI; intravitreal aflibercept injection; VE
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; BCVA; best-corrected visual acuity; CI; confidence interval; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; IAI; intravitreal aflibercept injection; LS; least square; NPDR; nonproliferative diabeti
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; BCVA; best-corrected visual acuity; DME; diabetic macular edema; DR; diabetic retinopathy; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysis set; NPDR; nonproliferative diabetic retinopathy; P
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; DME; diabetic macular edema; DR; diabetic retinopathy; DRCR.net; Diabetic Retinopathy Clinical Research Network; DRSS; diabetic retinopathy severity scale; ETDRS; Early Treatment Diabetic Retinopathy Study; FAc; fluocinolone acetonide; FAME; Fluocinolone
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Diabetic Retinopathy Severity Scale; ETDRS; Early Treatment Diabetic Retinopathy Study; IAI; intravitreal aflibercept injection; SD; standard deviation
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; aLOCF; last observation carried forward, including measurements after additional or PRN treatment was given; AMD; age-related macular degeneration; BCVA; best-corrected visual acuity; CST; central subfield thickness; DME; diabetic macular edema; DRSS; Dia
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; 2q4; 2 mg every 4 weeks; 2q8; 2 mg every 8 weeks after 5 initial monthly doses; AE; adverse event; aLOCF; last observation carried forward, including measurements after rescue treatment was given; BCVA; best-corrected visual acuity; CST; central (optical
Intravitreal Aflibercept for Diabetic Macular Edema
Keywords: مقیاس شدت گیری رتینوپاتی دیابتی; aLOCF; last observation carried forward, including values after additional treatment was given; BCVA; best-corrected visual acuity; CST; central (optical coherence tomography) subfield thickness; DME; diabetic macular edema; DRCR.net; Diabetes Retinopathy